References
- Keenan TDL, Wotton CJ, Goldacre MJ. Trends over time and geographical variation in rates of intravitreal injections in England. Br J Ophthalmol. 2012;96:413. doi:https://doi.org/10.1136/bjophthalmol-2011-300338.
- Wu L, Berrocal MH, Arévalo JF, et al. Endophthalmitis after pars plana vitrectomy: results of the Pan American Collaborative Retina Study Group. Retina. 2011;31:673–678. doi:https://doi.org/10.1097/IAE.0b013e318203c183.
- Kuriyan AE, Weiss KD, Flynn HW Jr, et al. Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes. Am J Ophthalmol. 2014;157:774–780.e1. doi:https://doi.org/10.1016/j.ajo.2013.12.026.
- Busch C, Iglicki M, Okada M, et al. Causative pathogens of endophthalmitis after intravitreal anti-VEGF Injection: an International multicenter study. Ophthalmologica. 2019;241:211–219. doi:https://doi.org/10.1159/000496942.
- Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13:388–391.
- Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “Hand motion” and “Counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47:1236–1240. doi:https://doi.org/10.1167/iovs.05-0981.
- Eifrig CWG, Flynn HW, Scott IU. Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995–2001). Ophthalmic Surg Lasers. 2002;33:373–378.
- Eifrig CW, Scott IU, Flynn HW, et al. Endophthalmitis after pars plana vitrectomy: incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol. 2004;138:799–802. doi:https://doi.org/10.1016/j.ajo.2004.06.035.
- Mccannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina. 2011;31:654–661. doi:https://doi.org/10.1097/IAE.0b013e31820a67e4.
- Fileta JB, Scott IU, Flynn HW Jr. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthal Surg Laser Imaging Retina. 2014;45:143–149. doi:https://doi.org/10.3928/23258160-20140306-08.
- Meredith TA, McCannel CA, Barr C, et al. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2015;122:817–821. doi:https://doi.org/10.1016/j.ophtha.2014.10.027.
- Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask. Graefes Arch Clin Exp Ophthalmol. 2013;251:1885–1890. doi:https://doi.org/10.1007/s00417-013-2274-y.
- Bhende M, Raman R, Jain M, et al. Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital. Plos ONE. 2018;13:e0191173. doi:https://doi.org/10.1371/journal.pone.0191173.
- Sharma S, Padhi TR, Basu S, Kar S, Roy A, Das T. Endophthalmitis patients seen in a tertiary eye care centre in Odisha: a clinico-microbiological analysis. Indian J Med Res. 2014;139:91.
- Anand AR, Therese KL, Madhavan HN. Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol. 2000;48:123.
- Jambulingam M, Parameswaran SK, Lysa S, Selvaraj M, Madhavan HN. A study on the incidence, microbiological analysis and investigations on the source of infection of postoperative infectious endophthalmitis in a tertiary care ophthalmic hospital: an 8-year study. Indian J Ophthalmol. 2010;58:297. doi:https://doi.org/10.4103/0301-4738.64132.
- Cohen SM, Flynn HW, Murray TG, et al. Endophthalmitis after pars plana vitrectomy. Ophthalmology. 1995;102:705–712. doi:https://doi.org/10.1016/S0161-6420(95)30965-7.
- Joondeph BC, Blanc JP, Polkinghorne PJ. Endophthalmitis after pars plana vitrectomy: a New Zealand experience. Retina. 2005;25:587–589. doi:https://doi.org/10.1097/00006982-200507000-00008.
- Chen JK, Khurana RN, Nguyen QD, Do DV. The incidence of endophthalmitis following transconjunctival sutureless 25- vs 20-gauge vitrectomy. Eye. 2009;23:780–784. doi:https://doi.org/10.1038/eye.2008.160.
- Turhan V, Mutluoglu M, Acar A, et al. Increasing incidence of Gram-negative organisms in bacterial agents isolated from diabetic foot ulcers. J Infect Dev Ctries. 2013;7(10):707±712. doi:https://doi.org/10.3855/jidc.2967.
- Mishra C, Lalitha P, Rameshkumar G, et al. Incidence of endophthalmitis after intravitreal injections: risk factors, microbiology profile, and clinical outcomes. Ocul Immunol Inflamm. 2018;26:559–568. doi:https://doi.org/10.1080/09273948.2018.1430238.
- Moss JM, Sanislo SR, Ta CN. Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections. Ophthalmology. 2010;117:2141–2145. doi:https://doi.org/10.1016/j.ophtha.2010.02.030.
- Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ. Antibiotic resistance of conjunctiva and nasopharynx evalu- ation study: a prospective study of patients undergoing intravit- real injections. Ophthalmology. 2010;117:2372–2378. doi:https://doi.org/10.1016/j.ophtha.2010.03.034.
- Mistlberger A, Ruckhofer J, Raithel E, et al. Anterior chamber contamination during cataract surgery with intraocular lens implantation. J Cataract Refr Surg. 1997;23:1064–1069. doi:https://doi.org/10.1016/S0886-3350(97)80081-8.
- Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina. 2011;31:1525–1533. doi:https://doi.org/10.1097/IAE.0b013e318221594a.
- Yin VT, Weisbrod DJ, Eng KT, et al. Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol. 2013;131:456–461. doi:https://doi.org/10.1001/jamaophthalmol.2013.2379.
- Garg SJ, Dollin M, Storey P, et al. Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy. Retina. 2016;36:351–359. doi:https://doi.org/10.1097/IAE.0000000000000694.
- JC P, Ramasamy B, Shaw S, Prasad S, Ling RH. A prospective and nationwide study investigating endophthalmitis following pars plana vitrectomy: incidence and risk factors. Br J Ophthalmol. 2014;98:529–533. doi:https://doi.org/10.1136/bjophthalmol-2013-304485.
- Scott IU, Flynn HW, Acar N, et al. Incidence of endophthalmitis after 20-gauge vs 23-gauge vs 25-gauge pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2011;249:377–380. doi:https://doi.org/10.1007/s00417-010-1505-8.
- Cheung CSY, Wong AWT, Lui A, Kertes PJ, Devenyi RG, Lam WC. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology. 2012;119:1609–1614. doi:https://doi.org/10.1016/j.ophtha.2012.02.014.
- VanderBeek BL, Bonaffini SG, Ma L. The association between intravitreal steroids and post-injection endophthalmitis rates. Ophthalmology. 2015 Nov;122(11):2311–2315.e1. doi:https://doi.org/10.1016/j.ophtha.2015.07.005.
- Peyman GA. Antibiotic administration in the treatment of bacterial endophthalmitis. II Intravitreal injection. Surv Ophthalmol. 1977;21:332–346.
- Lisboa T, Waterer G, Rello J. We should be measuring genomic bacterial load and virulence factors. Crit Care Med. 2010;38:S656–S662. doi:https://doi.org/10.1097/CCM.0b013e3181f2453a.
- The American Society of Retina Specialists (ASRS). Preferences and Trends (PAT) Surveys. Chicago, IL: ASRS; 2013.
- Abell RG, Kerr NM, Allen P, Vote BJ. Intravitreal injections: is there benefit for a theatre setting? Br J Ophthalmol. 2012;96:1474–1478. doi:https://doi.org/10.1136/bjophthalmol-2012-302030.
- Casparis H, Wolfensberger TJ, Becker M, et al. Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study. Retina. 2014;34:12–17. doi:https://doi.org/10.1097/IAE.0b013e31829f74b0.
- Kunimoto DY, Kaiser RS. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology. 2007;114:2133–2137. doi:https://doi.org/10.1016/j.ophtha.2007.08.009.
- Ta CN, Egbert PR, Singh K, et al. Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology. 2002;109:2036–2040. doi:https://doi.org/10.1016/S0161-6420(02)01236-8.
- Halachmi-Eyal O, Lang Y, Keness Y, Miron D. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg. 2009; 35:2109–2114.
- Schechter RJ. Suture-wick endophthalmitis with sutured posterior chamber intraocular lenses. J Cataract Refract Surg. 1990;16:755–756. doi:https://doi.org/10.1016/S0886-3350(13)81021-8.
- Heilskov T, Joondeph BC, Olsen KR, Blankenship GW. Late endophthalmitis after transscleral fixation of a posterior chamber intraocular lens. Arch Ophthalmol. 1989;107:1427. doi:https://doi.org/10.1001/archopht.1989.01070020501017.
- Nb K, Kohli P, Pangtey BPS, Ramasamy K. Evaluation of sutureless, glueless, flapless, intrascleral fixated posterior chamber intraocular lens in children with ectopia lentis. J Ophthalmol. 2018;29:3212740.
- Scharioth GB, Prasad S, Georgalas I, Tataru C, Pavlidis M. Intermediate results of sutureless intrascleral posterior chamber intraocular lens fixation. J Cataract Refract Surg. 2010;36:254–259. doi:https://doi.org/10.1016/j.jcrs.2009.09.024.